Digital Diabetes Management: A Literature Review of Smart Insulin Pens.


Journal

Journal of diabetes science and technology
ISSN: 1932-2968
Titre abrégé: J Diabetes Sci Technol
Pays: United States
ID NLM: 101306166

Informations de publication

Date de publication:
05 2022
Historique:
pubmed: 13 1 2021
medline: 3 6 2022
entrez: 12 1 2021
Statut: ppublish

Résumé

Digital health management is increasingly pivotal in the care of patients with diabetes. The aim of this review was to evaluate the clinical benefits of using smart insulin pens with connectivity for diabetes management. The search was performed using PubMed and PubMed Central on May 15, 2019, to identify publications investigating the use of insulin pens. Studies evaluating insulin pens with connectivity via Bluetooth/Near Field Communication, with an associated electronic device enabling connectivity, or with a memory function were included in the review. Nine studies were identified in the search. Overall, these studies lacked data on smart insulin pens with a connectivity function, with eight of the available studies investigating only pens with a memory function. The studies focused primarily on assessing patient preference, usability, and technical accuracy. The number of studies assessing clinical outcomes was small (

Identifiants

pubmed: 33430644
doi: 10.1177/1932296820983863
pmc: PMC9158248
doi:

Substances chimiques

Hypoglycemic Agents 0
Insulin 0

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

587-595

Commentaires et corrections

Type : CommentIn

Références

J Diabetes Sci Technol. 2009 Mar 01;3(2):312-9
pubmed: 20144362
Patient Prefer Adherence. 2013 Apr 05;7:285-92
pubmed: 23630416
Curr Med Res Opin. 2006 Feb;22(2):315-25
pubmed: 16466603
J Multidiscip Healthc. 2014 Jul 02;7:267-82
pubmed: 25061317
Diabetes Care. 2019 Mar;42(3):345-348
pubmed: 30787056
Diabetes Technol Ther. 2020 Jan;22(1):19-24
pubmed: 31483167
Diabetes Care. 2018 Nov;41(11):2370-2376
pubmed: 30201847
J Diabetes Sci Technol. 2018 May;12(3):551-553
pubmed: 29411641
Med Devices (Auckl). 2016 Jan 07;9:11-8
pubmed: 26793007
Expert Opin Drug Deliv. 2012 Apr;9(4):355-6
pubmed: 22432521
Diabetes Metab. 2019 Sep;45(4):322-329
pubmed: 30243616
J Diabetes Sci Technol. 2012 Nov 01;6(6):1392-7
pubmed: 23294785
Diabetes Care. 2019 Mar;42(3):400-405
pubmed: 30352896
Patient Prefer Adherence. 2016 Sep 22;10:1869-1879
pubmed: 27703334
Diabetes Care. 2018 Dec;41(12):2669-2701
pubmed: 30291106
Curr Med Res Opin. 2012 Sep;28(9):1455-63
pubmed: 22640459
Diabetes Technol Ther. 2019 Apr;21(4):209-214
pubmed: 30896261
Int J Pharm Investig. 2016 Jan-Mar;6(1):1-9
pubmed: 27014614
Diabetes Technol Ther. 2020 Oct;22(10):709-718
pubmed: 32003590
Diabetes Technol Ther. 2010 Jun;12 Suppl 1:S73-7
pubmed: 20515311
Diabet Med. 2019 May;36(5):531-538
pubmed: 30773681
J Diabetes Sci Technol. 2010 Nov 01;4(6):1468-75
pubmed: 21129343
P T. 2014 Dec;39(12):866-76
pubmed: 25516696
Can J Diabetes. 2017 Feb;41(1):102-107
pubmed: 27600025
Curr Opin Allergy Clin Immunol. 2017 Apr;17(2):153-159
pubmed: 28118240
Diabetes Spectr. 2018 Nov;31(4):354-358
pubmed: 30510392
Patient Prefer Adherence. 2014 May 23;8:775-88
pubmed: 24920889
J Diabetes Sci Technol. 2015 Dec 20;10(1):35-41
pubmed: 26685994
J Gen Intern Med. 2002 Apr;17(4):243-52
pubmed: 11972720
Curr Hypertens Rep. 2019 Apr 25;21(6):44
pubmed: 31025117
Chronic Illn. 2014 Dec;10(4):303-13
pubmed: 24567195
Diabetes Care. 2013 Mar;36(3):543-9
pubmed: 23193208
Expert Rev Med Devices. 2007 Nov;4(6):793-802
pubmed: 18035945
Diabetes Care. 2010 Mar;33(3):595-601
pubmed: 20040654
Diabetes Care. 2019 Jun;42(6):1129-1131
pubmed: 30862650

Auteurs

Lutz Heinemann (L)

Science Consulting in Diabetes GmbH, Neuss, Germany.

Oliver Schnell (O)

Forschergruppe Diabetes e.V. at the Helmholtz Center, Munich, Germany.

Bernhard Gehr (B)

m&i-Fachklinik, Bad Heilbrunn, Germany.

Nanette C Schloot (NC)

Lilly Deutschland GmbH, Bad Homburg, Germany.

Sven W Görgens (SW)

Lilly Deutschland GmbH, Bad Homburg, Germany.

Christoph Görgen (C)

Lilly Deutschland GmbH, Bad Homburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH